Leukemia. 2012 Apr;26(4):822-4. doi: 10.1038/leu.2011.284. Epub 2011 Oct 14.

Interest of the association azacitidine-lenalidomide as frontline therapy in high-risk myelodysplasia or acute myeloid leukemia with complex karyotype.

Scherman E, Malak S, Perot C, Gorin NC, Rubio MT, Isnard F.

PMID:: 21997572; [PubMed - in process]

Publication Types

Letter

LinkOut - more resources

Full Text Sources

Supplemental Content

Save items

Related citations in PubMed

Clinical effect of increasing doses of lenalidomide in high-risk myelodysplastic syndrome and acute myeloid leukemia with chromosome 5 abnormalities. [Haematologica. 2011]
Clinical effect of increasing doses of lenalidomide in high-risk myelodysplastic syndrome and acute myeloid leukemia with chromosome 5 abnormalities.
Möllgård L, Saft L, Treppendahl MB, Dybedal I, Nørgaard JM, Astermark J, Ejerblad E, Garelius H, Dufva IH, Jansson M, et al. Haematologica. 2011 Jul; 96(7):963-71.
Review In vivo effects of decitabine in myelodysplasia and acute myeloid leukemia: review of cytogenetic and molecular studies. [Ann Hematol. 2005]
Review In vivo effects of decitabine in myelodysplasia and acute myeloid leukemia: review of cytogenetic and molecular studies.
Hackanson B, Robbel C, Wijermans P, Lübbert M. Ann Hematol. 2005 Dec; 84 Suppl 1:32-8.
Azacitidine in a patient with newly diagnosed acute myeloid leukemia and poor risk cytogenetics: outcomes of prolonged therapy. [Leuk Res. 2012]
Azacitidine in a patient with newly diagnosed acute myeloid leukemia and poor risk cytogenetics: outcomes of prolonged therapy.
Pappa V, Girkas K, Sambani C, Pagageorgiou S, Tsirigiotis P, Karvounis K, Stathopoulou E, Economopoulos T, Dimitriadis G, Dervenoulas I. Leuk Res. 2012 Apr; 36(4):e78-80. Epub 2011 Dec 26.
Pure erythroid leukemia: a reassessment of the entity using the 2008 World Health Organization classification. [Mod Pathol. 2011]
Pure erythroid leukemia: a reassessment of the entity using the 2008 World Health Organization classification.
Liu W, Hasserjian RP, Hu Y, Zhang L, Miranda RN, Medeiros LJ, Wang SA. Mod Pathol. 2011 Mar; 24(3):375-83. Epub 2010 Nov 19.
Review Myelodysplasia: when to treat and how. [Best Pract Res Clin Haematol. ...]
Review Myelodysplasia: when to treat and how.
Larson RA. Best Pract Res Clin Haematol. 2006; 19(2):293-300.

See reviews... See all...

Recent activity

Clear Turn Off Turn On

Interest of the association azacitidine-lenalidomide as frontline therapy in hig...
Interest of the association azacitidine-lenalidomide as frontline therapy in high-risk myelodysplasia or acute myeloid leukemia with complex karyotype.
Leukemia. 2012 Apr ;26(4):822-4. doi: 10.1038/leu.2011.284. Epub 2011 Oct 14 .

PubMed
Purpuric rash revealing epilepsy.
Purpuric rash revealing epilepsy.
Eur Neurol. 2011 ;66(5):264. Epub 2011 Oct 13 .

PubMed
Ocular trauma: from epidemiology to war-related injuries.
Ocular trauma: from epidemiology to war-related injuries.
Graefes Arch Clin Exp Ophthalmol. 2011 Dec ;249(12):1753-4. Epub 2011 Oct 14 .

PubMed
Concurrent atazanavir and voriconazole in a patient with multidrug-resistant HIV...
Concurrent atazanavir and voriconazole in a patient with multidrug-resistant HIV and a mycetoma.
AIDS. 2011 Oct 23 ;25(16):2054-6.

PubMed
Abdominal wall reconstruction with intraperitoneal prosthesis in desmoid tumors ...
Abdominal wall reconstruction with intraperitoneal prosthesis in desmoid tumors surgery.
Updates Surg. 2012 Mar ;64(1):43-8. Epub 2011 Oct 14 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

Interest of the association azacitidine-lenalidomide as frontline therapy in high-risk myelodysplasia or acute myeloid leukemia with complex karyotype.

Publication Types

Publication Types

LinkOut - more resources

Full Text Sources

Supplemental Content

Save items

Related citations in PubMed

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information